Traws Pharma Q3 EPS $(0.18) Beats $(0.20) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 47.06 percent increase over losses of $(0.34) per share from the
Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 47.06 percent increase over losses of $(0.34) per share from the same period last year.
